|
|
UPDATE : Monday, September 7, 2020
 |
상단여백
|
SillaJen to receive $4 million milestone thanks to ‘Pexa-Vec’1st European patient enrolled in Phase 3 trial of liver cancer therapy
|
||||||
|
|
|
|||||
![[Column] Correct diagnosis leads to proper treatment](/news/thumbnail/202009/9116_8842_102_v150.jpg)
![[Column] How ongoing doctors’ strike is different from 20 years ago](/news/thumbnail/202008/9049_8793_732_v150.jpg)
- About KBR
- Tip off
- Advertising
- Site Feedback
- Privacy Policy
- Adolescent Protection Policy
- E-mail address privacy
The Korean Doctors’ Weekly Co., Ltd. | 76-1, Dongmak-ro, Mapo-gu, Seoul, Korea | Tel 82-2-2646-0852 | Fax 82-2-703-3916 | Email : webmaster@docdocdoc.co.kr
Title : Korea Biomedical Review | Online newspaper registration number : Seoul 아 04285 | Date of registration : December 19, 2016 | Publishing date? : February 22, 2017
Publisher-Editor : Yang Kyung-cheol | Chief Executive Officer : Yang Kyung-cheol | Executive Editor : Choi Sung-jin
Copyright © 2024 KBR. All rights reserved.
Title : Korea Biomedical Review | Online newspaper registration number : Seoul 아 04285 | Date of registration : December 19, 2016 | Publishing date? : February 22, 2017
Publisher-Editor : Yang Kyung-cheol | Chief Executive Officer : Yang Kyung-cheol | Executive Editor : Choi Sung-jin
Copyright © 2024 KBR. All rights reserved.
